Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huan-Rong Lan

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Oxidative Medicine and Cellular Longevity|September 2, 2021
A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory ActivitiesLi-Feng Hu, Huan-Rong Lan, Xue-Min Li, et al.
International Immunopharmacology|September 28, 2023
Could immunoscore improve the prognostic and therapeutic management in patients with solid tumors?Jing-Lun Xu, Meng-Xiang Yang, Huan-Rong Lan, et al.
Frontiers in Oncology|December 10, 2021
Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?Li-Feng Hu, Huan-Rong Lan, Dong Huang, et al.
International Immunopharmacology|January 24, 2024
Novel immunotherapies for breast cancer: Focus on 2023 findingsHuan-Rong Lan, Min Chen, Shi-Ya Yao, et al.
Frontiers in Immunology|December 19, 2023
Bispecific antibodies revolutionizing breast cancer treatment: a comprehensive overviewHuan-Rong Lan, Min Chen, Shi-Ya Yao, et al.
Current Topics in Medicinal Chemistry|July 25, 2020
Nanotechnology Assisted Chemotherapy for Targeted Cancer Treatment: Recent Advances and Clinical PerspectivesHuan-Rong Lan, Zhi-Qiang Wu, Li-Hua Zhang, et al.
Frontiers in Immunology|April 22, 2022
Organoid Models for Precision Cancer ImmunotherapyCai-Ping Sun, Huan-Rong Lan, Xing-Liang Fang, et al.
International Immunopharmacology|April 16, 2021
Role of immune regulatory cells in breast cancer: Foe or friend?Huan-Rong Lan, Wen-Lin Du, Yuyao Liu, et al.
Experimental Cell Research|October 3, 2021
Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the moldLi-Feng Hu, Xue Yang, Huan-Rong Lan, et al.
Cancers|February 6, 2021
Oncolytic Virotherapy in Solid Tumors: The Challenges and AchievementsKe-Tao Jin, Wen-Lin Du, Yu-Yao Liu, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Oxidative Medicine and Cellular Longevity|September 2, 2021
A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory ActivitiesLi-Feng Hu, Huan-Rong Lan, Xue-Min Li, et al.
International Immunopharmacology|September 28, 2023
Could immunoscore improve the prognostic and therapeutic management in patients with solid tumors?Jing-Lun Xu, Meng-Xiang Yang, Huan-Rong Lan, et al.
Frontiers in Oncology|December 10, 2021
Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?Li-Feng Hu, Huan-Rong Lan, Dong Huang, et al.
International Immunopharmacology|January 24, 2024
Novel immunotherapies for breast cancer: Focus on 2023 findingsHuan-Rong Lan, Min Chen, Shi-Ya Yao, et al.
Frontiers in Immunology|December 19, 2023
Bispecific antibodies revolutionizing breast cancer treatment: a comprehensive overviewHuan-Rong Lan, Min Chen, Shi-Ya Yao, et al.
Current Topics in Medicinal Chemistry|July 25, 2020
Nanotechnology Assisted Chemotherapy for Targeted Cancer Treatment: Recent Advances and Clinical PerspectivesHuan-Rong Lan, Zhi-Qiang Wu, Li-Hua Zhang, et al.
Frontiers in Immunology|April 22, 2022
Organoid Models for Precision Cancer ImmunotherapyCai-Ping Sun, Huan-Rong Lan, Xing-Liang Fang, et al.
International Immunopharmacology|April 16, 2021
Role of immune regulatory cells in breast cancer: Foe or friend?Huan-Rong Lan, Wen-Lin Du, Yuyao Liu, et al.
Experimental Cell Research|October 3, 2021
Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the moldLi-Feng Hu, Xue Yang, Huan-Rong Lan, et al.
Cancers|February 6, 2021
Oncolytic Virotherapy in Solid Tumors: The Challenges and AchievementsKe-Tao Jin, Wen-Lin Du, Yu-Yao Liu, et al.
Pageof 2